RE:RE:BNNGood post. Worthy of bump!
prophetoffacts wrote: "Why dose Gilles not arrange a interview with BNN to get some exposure...many investors watch that channel. Jenene you reading this ????"
What would he say...
We haven't even completed efficacy studies in mice for COVID let alone in humans or even made a filing to commence trials...
We haven't even completed a bioavailability study for the CoQ10 New Chemical Complex let alone a license...
We are still working to install commercial-scale PGX equipment after recently gaining access to the facility after COVID restrictions...
When CZO has completed the COVID efficacy study in mice and filed for a human clinical trial. When it has completed the bioavailability study for the CoQ10 complex. When it has installed the commercial-scale PGX equipment it recently acquired and demonstrated that it works. When it has completed the avenanthramide mice studies and filed for a human clinical trial. When it has the cholesterol lowering pill human data in hand. When it has completed the aforementioned it will be at a whole new level and be ready for revaluation. Until then it is too early to promote. It is also too risky given the risks to the timeline of early stage developments. After the foundation is set with the above events over this year it will be ready for a revaluation and the US uplisting. It will be on a solid foundation.